Results 221 to 230 of about 2,223,665 (257)

Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation. [PDF]

Cell Mol Life Sci
He G, Shao W, Wang W, Sun L, Gao B, Wei J.   +5 more
europepmc   +1 more source

MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma. [PDF]

Int J Mol Sci
Leoni I, Galvani G, Monti E, Vianello C, Valenti F, Pincigher L, Grolla AA, Moro M, Coada CA, Perrone A, Righi V, Marinelli S, Ravegnini G, Giovannini C, Baldassarre M, Pariali M, Ravaioli M, Cescon M, Vasuri F, Domenicali M, Negrini M, Piscaglia F, Fato R, Stefanelli C, Gramantieri L, Bergamini C, Fornari F.   +26 more
europepmc   +1 more source

Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis. [PDF]

Biomater Res
Feng W, Xu J, Chen B, Liu J, Hu Y, Cao X, Qi J, Ju L, Shao J, Dong P, Chen L, Wang F.   +11 more
europepmc   +1 more source

miR-199a-5p/GPR89A axis modulates sorafenib resistance in hepatocellular carcinoma through glutamate metabolic reprogramming. [PDF]

Sci Prog
Li Y, Cai Y, Duan G, Du Y, Hu J, Han X, Tang X, Jiang L, Ren J, Huo Q.   +9 more
europepmc   +1 more source

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity. [PDF]

Clin Transl Med
Wang X, Su Y, Lan B, Li X, Zhang B, Zhang L, Wang Y, Zhang C, Xuan C.   +8 more
europepmc   +1 more source

Increased CAPG inhibits ferroptosis to drive tumor proliferation and sorafenib resistance in hepatocellular carcinoma via the WDR74-p53-SLC7A11 pathway. [PDF]

Int J Biol Sci
Quan B, Yao F, Liu W, Tang B, Li M, Lu S, Li J, Chen R, Ren Z, Yin X.   +9 more
europepmc   +1 more source

Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. [PDF]

Int J Biol Sci
Ruan Y, Chen T, Zheng L, Cai J, Zhao H, Wang Y, Tao L, Xu J, Ji L, Cai X.   +9 more
europepmc   +1 more source

Exploring the potential mechanisms of sorafenib resistance in hepatocellular carcinoma cell lines based on RNA sequencing. [PDF]

Cancer Cell Int
Sun M, Zhang Z, Chen C, Zhong J, Long Z, Shen L, Huang H, Lu J.   +7 more
europepmc   +1 more source

ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer. [PDF]

Transl Oncol
Lin YH, Chen CY, Chi HC, Wu MH, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source

The Emerging Role of Long Noncoding RNAs in Sorafenib Resistance Within Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Vij P, Hussain MS, Satapathy SK, Cobos E, Tripathi MK.   +4 more
europepmc   +1 more source